Spectroscopic features of cytochrome P450 reaction intermediates

被引:105
|
作者
Luthra, Abhinav [1 ]
Denisov, Ilia G. [1 ]
Sligar, Stephen G. [1 ]
机构
[1] Univ Illinois, Sch Mol & Cellular Biol, Dept Biochem, Urbana, IL 61801 USA
关键词
Cytochrome P450; Spectroscopy; Metalloenzyme mechanisms; MAGNETIC CIRCULAR-DICHROISM; ELECTRON-PARAMAGNETIC-RESONANCE; CHLOROPEROXIDASE COMPOUND-I; PSEUDOMONAS-PUTIDA CYTOCHROME-P-450; RESOLUTION CRYSTAL-STRUCTURES; CARBON-MONOXIDE BINDING; PI-CATION RADICALS; ACTIVE-SITE; RAMAN-SPECTROSCOPY; LOW-TEMPERATURE;
D O I
10.1016/j.abb.2010.12.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochromes P450 constitute a broad class of heme monooxygenase enzymes with more than 11,500 isozymes which have been identified in organisms from all biological kingdoms [1]. These enzymes are responsible for catalyzing dozens chemical oxidative transformations such as hydroxylation, epoxidation, N-demethylation, etc., with very broad range of substrates [2,3]. Historically these enzymes received their name from 'pigment 450' due to the unusual position of the Soret band in UV-vis absorption spectra of the reduced CO-saturated state [4,5]. Despite detailed biochemical characterization of many isozymes, as well as later discoveries of other 'P450-like heme enzymes' such as nitric oxide synthase and chloroperoxidase, the phenomenological term 'cytochrome P450' is still commonly used as indicating an essential spectroscopic feature of the functionally active protein which is now known to be due to the presence of a thiolate ligand to the heme iron [6]. Heme proteins with an imidazole ligand such as myoglobin and hemoglobin as well as an inactive form of P450 are characterized by Soret maxima at 420 nm [7]. This historical perspective highlights the importance of spectroscopic methods for biochemical studies in general, and especially for heme enzymes, where the presence of the heme iron and porphyrin macrocycle provides rich variety of specific spectroscopic markers available for monitoring chemical transformations and transitions between active intermediates of catalytic cycle. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:26 / 35
页数:10
相关论文
共 50 条
  • [31] Spectroscopic characterization of the iron-oxo intermediate in cytochrome P450
    Jung, C
    Schünemann, V
    Lendzian, F
    Trautwein, AX
    Contzen, J
    Galander, M
    Böttger, LH
    Richter, M
    Barra, AL
    BIOLOGICAL CHEMISTRY, 2005, 386 (10) : 1043 - 1053
  • [32] Cytochrome P450 database
    Lisitsa, AV
    Gusev, SA
    Karuzina, II
    Archakov, AI
    Koymans, L
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2001, 12 (04) : 359 - 366
  • [33] Cytochrome P450 biodiversity
    不详
    JOURNAL OF PESTICIDE SCIENCE, 1996, 21 (01) : 111 - 114
  • [34] The cytochrome P450 homepage
    Nelson D.R.
    Human Genomics, 4 (1) : 59 - 65
  • [35] Cytochrome P450 monooxygenases
    Wong, LL
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (02) : 263 - 268
  • [36] CYTOCHROME P450 TURNOVER
    CORREIA, MA
    METHODS IN ENZYMOLOGY, 1991, 206 : 315 - 325
  • [37] Cytochrome P450 flexibility
    Poulos, TL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) : 13121 - 13122
  • [38] SYNTHESIS OF POTENTIAL CYTOCHROME P450(11-BETA)-GENERATED INTERMEDIATES
    COUSTAL, S
    FAGART, J
    DAVIOUD, E
    MARQUET, A
    TETRAHEDRON, 1995, 51 (12) : 3559 - 3570
  • [39] Cytochrome P450 biotechnology
    Gilardi, Gianfranco
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2013, 60 (01) : 1 - 1
  • [40] Cytochrome P450 and atherosclerosis
    Luoma, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (04) : 484 - 484